| Code | Description | Claims | Beneficiaries | Total Paid |
| 0450 |
Emergency room services |
44,999 |
38,881 |
$468K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,443 |
3,997 |
$373K |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
7,751 |
4,761 |
$321K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
12,105 |
10,409 |
$274K |
| G0378 |
Hospital observation service, per hour |
1,096 |
734 |
$249K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,288 |
1,259 |
$201K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,175 |
3,993 |
$182K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,820 |
8,337 |
$157K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
17,870 |
15,672 |
$138K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,365 |
6,739 |
$135K |
| 80053 |
Comprehensive metabolic panel |
31,354 |
26,276 |
$127K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,592 |
2,359 |
$124K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,848 |
4,493 |
$124K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,495 |
3,872 |
$103K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
33,945 |
27,222 |
$97K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,627 |
7,922 |
$85K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
16,480 |
11,121 |
$79K |
| J3490 |
Unclassified drugs |
26,587 |
10,584 |
$74K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,851 |
7,489 |
$72K |
| 71045 |
Radiologic examination, chest; single view |
14,466 |
12,997 |
$68K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
742 |
697 |
$65K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,204 |
4,554 |
$57K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
1,719 |
1,530 |
$57K |
| 36430 |
|
376 |
211 |
$49K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
3,213 |
2,444 |
$47K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,056 |
1,925 |
$46K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,557 |
2,323 |
$44K |
| 93971 |
|
829 |
779 |
$43K |
| 84484 |
|
11,593 |
9,911 |
$40K |
| 99199 |
Unlisted special service, procedure or report |
1,173 |
1,080 |
$40K |
| 83880 |
|
3,752 |
3,330 |
$37K |
| J7050 |
Infusion, normal saline solution, 250 cc |
11,716 |
6,574 |
$36K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,291 |
6,572 |
$35K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,257 |
1,188 |
$34K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,156 |
3,308 |
$34K |
| 83690 |
|
11,558 |
10,148 |
$31K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,525 |
3,267 |
$30K |
| 96376 |
|
4,371 |
2,539 |
$29K |
| Z9725 |
|
915 |
897 |
$27K |
| 84145 |
|
3,035 |
2,678 |
$25K |
| 83605 |
|
5,830 |
5,057 |
$23K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
598 |
582 |
$23K |
| 76830 |
Ultrasound, transvaginal |
829 |
777 |
$22K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
630 |
565 |
$22K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,368 |
1,410 |
$17K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
11,605 |
8,243 |
$16K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
446 |
399 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
21,882 |
16,184 |
$15K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,350 |
2,007 |
$14K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,371 |
2,693 |
$13K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
347 |
201 |
$11K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,602 |
3,272 |
$11K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
883 |
845 |
$11K |
| J2785 |
Injection, regadenoson, 0.1 mg |
353 |
307 |
$11K |
| 93970 |
|
211 |
198 |
$11K |
| 81025 |
|
6,203 |
5,598 |
$11K |
| 85379 |
|
2,397 |
2,204 |
$11K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
498 |
491 |
$10K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
372 |
336 |
$10K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
83 |
79 |
$10K |
| 82803 |
|
2,679 |
2,377 |
$10K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,928 |
4,209 |
$10K |
| 71250 |
|
377 |
357 |
$9K |
| 82533 |
|
1,715 |
1,325 |
$9K |
| 80305 |
|
1,508 |
1,387 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,354 |
2,967 |
$9K |
| 87040 |
|
1,947 |
1,577 |
$9K |
| C1769 |
Guide wire |
79 |
78 |
$9K |
| 36416 |
|
4,201 |
2,631 |
$8K |
| 81003 |
|
10,104 |
9,032 |
$8K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
264 |
258 |
$8K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
883 |
232 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,468 |
3,089 |
$8K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
344 |
322 |
$8K |
| 73630 |
|
783 |
742 |
$7K |
| 81001 |
|
6,293 |
5,634 |
$7K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
90 |
88 |
$7K |
| 0710 |
|
2,037 |
1,658 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,210 |
2,441 |
$7K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
473 |
418 |
$6K |
| 97162 |
|
536 |
446 |
$6K |
| 73030 |
|
717 |
689 |
$6K |
| 73610 |
|
522 |
493 |
$5K |
| 85610 |
|
5,111 |
4,398 |
$5K |
| 90715 |
|
295 |
272 |
$5K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
566 |
547 |
$5K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
173 |
164 |
$5K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
172 |
160 |
$5K |
| 84703 |
|
3,006 |
2,819 |
$5K |
| Z7502 |
|
122 |
115 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,087 |
1,016 |
$4K |
| 85730 |
|
2,849 |
2,410 |
$4K |
| J2060 |
Injection, lorazepam, 2 mg |
2,074 |
1,521 |
$4K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,703 |
526 |
$4K |
| 82947 |
|
8,456 |
3,737 |
$4K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
118 |
101 |
$4K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,506 |
1,359 |
$4K |
| 83735 |
|
2,151 |
1,515 |
$4K |
| 0270 |
|
23,552 |
9,814 |
$4K |
| 73562 |
|
459 |
447 |
$4K |
| 0370 |
|
1,358 |
1,103 |
$4K |
| 76801 |
|
120 |
100 |
$4K |
| 0272 |
|
4,247 |
3,051 |
$4K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,017 |
1,717 |
$4K |
| 93017 |
|
517 |
459 |
$3K |
| 73564 |
|
286 |
281 |
$3K |
| 96367 |
|
285 |
247 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
3,635 |
1,998 |
$3K |
| 85027 |
|
2,251 |
1,773 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
599 |
577 |
$3K |
| 87186 |
|
1,090 |
939 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
525 |
428 |
$3K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
26 |
26 |
$3K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,307 |
897 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,625 |
1,195 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
597 |
585 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
569 |
504 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
349 |
189 |
$2K |
| 0160 |
|
1,891 |
790 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
474 |
385 |
$2K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,488 |
1,085 |
$2K |
| 83874 |
|
546 |
462 |
$2K |
| 73110 |
|
191 |
182 |
$2K |
| 86923 |
|
340 |
216 |
$2K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
14 |
13 |
$2K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
229 |
220 |
$2K |
| 86901 |
|
2,546 |
1,782 |
$2K |
| J1815 |
Injection, insulin, per 5 units |
1,555 |
552 |
$2K |
| 86900 |
|
2,553 |
1,782 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,740 |
1,358 |
$2K |
| 84702 |
|
517 |
444 |
$2K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
41 |
39 |
$2K |
| 87088 |
|
688 |
611 |
$2K |
| 73130 |
|
164 |
158 |
$2K |
| 36592 |
|
67 |
37 |
$2K |
| 87077 |
|
640 |
531 |
$2K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
2,931 |
2,356 |
$2K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,989 |
1,311 |
$2K |
| 0250 |
|
20,850 |
5,091 |
$1K |
| 70496 |
|
13 |
12 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
690 |
577 |
$1K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
98 |
76 |
$1K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
725 |
318 |
$1K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
829 |
611 |
$1K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
66 |
65 |
$1K |
| 59025 |
Fetal non-stress test |
143 |
38 |
$1K |
| 72131 |
|
36 |
36 |
$1K |
| 87486 |
|
83 |
79 |
$1K |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,210 |
483 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
513 |
462 |
$1K |
| 86140 |
|
584 |
532 |
$1K |
| 80143 |
|
115 |
108 |
$1K |
| 87581 |
|
83 |
79 |
$996.76 |
| 80179 |
|
114 |
107 |
$993.73 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
83 |
79 |
$887.20 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,506 |
1,655 |
$885.00 |
| 86850 |
|
1,512 |
1,223 |
$879.90 |
| 84100 |
|
711 |
541 |
$872.24 |
| 71010 |
|
109 |
105 |
$774.28 |
| 82550 |
|
373 |
314 |
$767.00 |
| 0949 |
|
486 |
199 |
$526.23 |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
144 |
62 |
$476.36 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
94 |
54 |
$412.59 |
| 76775 |
|
27 |
27 |
$352.73 |
| 80061 |
Lipid panel |
124 |
113 |
$337.01 |
| 76642 |
|
14 |
14 |
$327.08 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
12 |
12 |
$280.53 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
12 |
12 |
$279.63 |
| 85007 |
|
215 |
196 |
$228.00 |
| 72100 |
|
27 |
25 |
$215.74 |
| 72141 |
|
13 |
12 |
$205.07 |
| 85652 |
|
173 |
168 |
$201.99 |
| 0301 |
|
1,042 |
243 |
$191.85 |
| 74018 |
|
27 |
25 |
$167.50 |
| 70486 |
|
13 |
12 |
$164.00 |
| 0360 |
|
260 |
134 |
$149.17 |
| 73080 |
|
14 |
14 |
$148.59 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
312 |
182 |
$133.81 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
38 |
38 |
$123.41 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
49 |
29 |
$99.49 |
| 80047 |
|
42 |
40 |
$98.05 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
70 |
55 |
$96.61 |
| 29515 |
|
16 |
13 |
$84.00 |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
14 |
13 |
$78.21 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
12 |
12 |
$69.61 |
| 82728 |
|
41 |
25 |
$68.61 |
| A9573 |
Injection, gadopiclenol, 1 ml |
27 |
26 |
$67.34 |
| 74240 |
|
51 |
51 |
$61.92 |
| 87147 |
|
30 |
25 |
$58.65 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
2,503 |
2,102 |
$54.55 |
| 29125 |
|
14 |
12 |
$44.01 |
| 87205 |
|
29 |
25 |
$43.24 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
13 |
12 |
$41.65 |
| 0300 |
|
152 |
66 |
$34.10 |
| A4217 |
Sterile water/saline, 500 ml |
31 |
25 |
$32.20 |
| 51702 |
|
22 |
16 |
$30.10 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
13 |
13 |
$27.77 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
38 |
35 |
$25.68 |
| 82565 |
|
28 |
26 |
$24.03 |
| 85014 |
|
57 |
55 |
$22.51 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
16 |
15 |
$22.33 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
18 |
14 |
$10.81 |
| 97116 |
|
14 |
12 |
$7.96 |
| 0351 |
|
33 |
26 |
$0.00 |
| 0302 |
|
79 |
67 |
$0.00 |
| 0760 |
|
236 |
186 |
$0.00 |
| 0320 |
|
99 |
71 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
49 |
45 |
$0.00 |
| 0402 |
|
89 |
51 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
26 |
25 |
$0.00 |
| 0762 |
|
20 |
12 |
$0.00 |
| 0306 |
|
247 |
141 |
$0.00 |
| 0636 |
|
401 |
123 |
$0.00 |
| 0305 |
|
456 |
207 |
$0.00 |
| 0720 |
|
40 |
33 |
$0.00 |
| 0352 |
|
133 |
94 |
$0.00 |
| 0307 |
|
78 |
57 |
$0.00 |
| 0258 |
|
58 |
34 |
$0.00 |
| 0324 |
|
151 |
117 |
$0.00 |
| 0379 |
|
57 |
55 |
$0.00 |